BioSpace News Archive

Follica, Inc., a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, epithelial aging and other related conditions, announced the publication of a pilot study evaluating scalp skin disruption to promote hair growth in female pattern hair loss in International Journal of Women’s Dermatology.

Calliditas Therapeutics AB announced that the company will host a Capital Markets Day in Stockholm, Sweden, on January 20, 2021 for investors, analysts and media.

Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the China National Medical Products Administration (NMPA) has approved and issued a Product license for the Company’s 23-Valent Pneumococcal Polysaccharide (“PPV”) Vaccine to prevent the infection by streptococcus pneumonia in adults and children ages 2 years old and above.

9 Meters Biopharma, Inc., a clinical-stage rare and unmet needs-focused gastroenterology company, announced that the United States Food and Drug Administration has granted orphan drug designation to NM-003, a proprietary long-acting GLP-2 receptor agonist, for prevention of acute graft versus host disease.

Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Margaret G. McGlynn, R. Ph. to its board as an independent director. Ms. McGlynn brings extensive pharmaceutical industry, vaccine and non-profit experience to her role on the Novavax Board of Directors. “Margie’s deep experience in vaccine commercialization and understandi

Virtual Panel of Nephrology Care Professionals to Share Insights and Experiences Managing Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis [09-December-2020] CAMBRIDGE, Mass. , Dec. 9, 2020 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disea

The National Kidney Foundation presents “Voice of the Patient Report: IgA Nephropathy” to federal agency

The demand within the global healthcare e-commerce market is growing on back of continuous advancements in the e-commerce industry and online sales of medication.

Orthopedic implant is a medical device used to replace missing joint and bone as well as to support a damaged bone. It is manufactured by using biomaterials and is coated by plastics.

Tissue plasminogen activator (tPA) is an enzyme associated with breakdown of blood clots (fibrinolysis).